Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%.

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

U.S. private equity firm Lone Star has told the Portuguese government that it is likely to sell a 25-30% stake in Novo Banco via an initial public offering, rather than seek a full sale, Finance ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...

Making the world smarter, happier, and richer.

Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

Resumo O presente trabalho apresenta reflexões sobre as contribuições oportunizadas pelos filmes de conversação de Eduardo Coutinho para delineamento de reflexões associadas ao conceito de sujeito ...

Vítima de acidente na Rota do Sol, soldado Juliano Baigorra deixa legado no Corpo de Bombeiros de Bento Gonçalves O bombeiro é uma das vítimas de um acidente ocorrido na manhã de domingo (26), na Rota ...